The Nuances of Patient Selection: Why Some Trials Need Eligibility Adjudication


Sponsored Content

Patient selection can be a nuanced process in clinical trials, particularly those involving therapeutic areas with more complex or subjective inclusion/exclusion criteria. Determining patient eligibility may often depend on factors that require clinical expertise in such areas as disease progression, comorbidities, genetic mutations, and disease severity. Discover the role eligibility adjudication committees play in ensuring trial success.

Related Content
© 2024 MJH Life Sciences

All rights reserved.